At a glance
- Originator Procter & Gamble
- Class Antirheumatics; Small molecules
- Mechanism of Action Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 18 Mar 1999 New profile
- 18 Mar 1999 Preclinical development for Inflammation in USA (Unknown route)